The Europe Cell and Gene Therapy Market Worth $15.15 Billion by 2028 - Exclusive Focus Insight Report by Arizton

According to Arizton's latest research report, the Europe cell and gene therapy market to grow at a CAGR of 38.20%, during the study period.

To Know More, Download the Free Sample Report: https://www.focusreports.store/request-sample/europe-cell-gene-therapy-market-focused-insights

The cell & gene therapy market in Europe is growing gradually due to the presence of advanced healthcare infrastructure, high acceptance of cell & gene therapies, and high per capita healthcare expenditure in various developed countries of Europe.

Why Do You Buy this Report?
Develop and design your in-licensing and out-licensing strategies to identify companies with the most robust pipelines

Develop business strategies by understanding the trends shaping and driving the Europe cell and gene therapy market

To analyze several micro-market indicators considering growth factors, market prospects, and contribution to the market strategically

To analyze several micro-market indicators considering growth factors, market prospects, and contribution to the market strategically

Key Developments
In December 2022, Anocca secured €25 million ($26.5 million) in venture debt financing from the European Investment Bank (EIB). This financing aims to advance the first generation of T-cell immunotherapies toward clinical trials in a solid tumor indication during 2024.
In December 2022, uniQure and its partner CSL received a positive opinion recommending conditional marketing authorization (CMA) from CHMP for etranacogene dezaparvovec for the treatment of adults with hemophilia B.
Myrtelle announced that the European Medicines Agency (EMA) granted orphan drug (OD) designation for rAAV-Olig001-ASPA for the treatment of Canavan disease.

Key Questions Answered in the Report:
How big is the Europe cell & gene therapy market?
Which European country has the largest share in the cell & gene therapy market?
Who are the key players in the cell & gene therapy market?

Table Of Contents
CHAPTER - 1: Cell & Gene Therapy Market Overview
Executive Summary
Introduction
Key Findings
Key Developments

CHAPTER - 2: Cell & Gene Therapy Market Segmentation Data
Europe: Projected Revenue of Cell & Gene Therapy (2022-2028; $Billions)
Product type
Application type
End-user type
EU5: Projected Revenue of Cell & Gene Therapy (2022-2028; $Billions)
Product type
Application type
End-user type
ROEU: Projected Revenue of Cell & Gene Therapy (2022-2028; $Billions)
Product type
Application type
End-user type
Germany: Projected Revenue of Cell & Gene Therapy (2022-2028; $Billions)
Product type
France: Projected Revenue of Cell & Gene Therapy (2022-2028; $Billions)
Product type
UK: Projected Revenue of Cell & Gene Therapy (2022-2028; $Billions)
Product type

Get the Detailed TOC @ https://www.focusreports.store/report/europe-cell-gene-therapy-market-focused-insights

About Focused Reports by Arizton   
Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing.    

Contact Us:   
Call: +1-312-235-2040                                              
          +1 302 469 0707                                             
Mail: enquiry@arizton.com  
Website: https://www.focusreports.store/   

This release was published on openPR.